Pharmacophore Modeling and Molecular Docking Led to the Discovery of Inhibitors of Human Immunodeficiency Virus-1 Replication Targeting the Human Cellular Aspartic Acid−Glutamic Acid−Alanine−Aspartic Acid Box Polypeptide 3

2008 ◽  
Vol 51 (21) ◽  
pp. 6635-6638 ◽  
Author(s):  
Giovanni Maga ◽  
Federico Falchi ◽  
Anna Garbelli ◽  
Amalia Belfiore ◽  
Myriam Witvrouw ◽  
...  
Keyword(s):  
Human Immunodeficiency Virus ◽  
Molecular Docking ◽  
Glutamic Acid ◽  
Aspartic Acid ◽  
Pharmacophore Modeling ◽  
Immunodeficiency Virus ◽  
Human Immunodeficiency Virus 1

Presence of antibodies to human immunodeficiency virus‐1 in reference reagents of human origin in diagnostic kits

1988 ◽  
Vol 148 (10) ◽  
pp. 503-505
Author(s):  
Felicity A. Brake ◽  
Alan M. Breschkin ◽  
Sunil S. Gandhi ◽  
William J. Maskill ◽  
Teresa S. Howard
Keyword(s):  
Human Immunodeficiency Virus ◽  
Human Origin ◽  
Diagnostic Kits ◽  
Immunodeficiency Virus ◽  
Human Immunodeficiency Virus 1

scholarly journals Interdomain hydrolysis of a truncated Pseudomonas exotoxin by the human immunodeficiency virus-1 protease.

1990 ◽  
Vol 265 (1) ◽  
pp. 408-413
Author(s):  
A G Tomasselli ◽  
J O Hui ◽  
T K Sawyer ◽  
D J Staples ◽  
D J FitzGerald ◽  
...  
Keyword(s):  
Human Immunodeficiency Virus ◽  
Pseudomonas Exotoxin ◽  
Immunodeficiency Virus ◽  
Hydrolysis Of ◽  
Human Immunodeficiency Virus 1

scholarly journals Identification and purification of the enhancer-binding factor of human immunodeficiency virus-1

1989 ◽  
Vol 264 (5) ◽  
pp. 2826-2831
Author(s):  
T Maekawa ◽  
F Itoh ◽  
T Okamoto ◽  
M Kurimoto ◽  
F Imamoto ◽  
...  
Keyword(s):  
Human Immunodeficiency Virus ◽  
Binding Factor ◽  
Immunodeficiency Virus ◽  
Human Immunodeficiency Virus 1
Sign in / Sign up

Export Citation Format

Share Document